FI58121C - Foerfarande foer framstaellning av farmakologiskt aktiva foereningar - Google Patents
Foerfarande foer framstaellning av farmakologiskt aktiva foereningar Download PDFInfo
- Publication number
- FI58121C FI58121C FI3404/73A FI340473A FI58121C FI 58121 C FI58121 C FI 58121C FI 3404/73 A FI3404/73 A FI 3404/73A FI 340473 A FI340473 A FI 340473A FI 58121 C FI58121 C FI 58121C
- Authority
- FI
- Finland
- Prior art keywords
- methyl
- bromide
- compound
- azobis
- dibromide
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 6
- 230000000694 effects Effects 0.000 title description 4
- 230000000144 pharmacologic effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims description 21
- 150000001450 anions Chemical class 0.000 claims description 10
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 claims description 9
- 125000000217 alkyl group Chemical group 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 5
- 125000003545 alkoxy group Chemical group 0.000 claims description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 4
- 125000004432 carbon atom Chemical group C* 0.000 claims description 3
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims description 3
- DPOPAJRDYZGTIR-UHFFFAOYSA-N Tetrazine Chemical compound C1=CN=NN=N1 DPOPAJRDYZGTIR-UHFFFAOYSA-N 0.000 claims description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 33
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 24
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 21
- 239000007787 solid Substances 0.000 description 20
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 18
- 239000000203 mixture Substances 0.000 description 17
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 14
- -1 nitro-substituted phenyl Chemical group 0.000 description 13
- 239000000243 solution Substances 0.000 description 11
- CDDDRVNOHLVEED-UHFFFAOYSA-N 1-cyclohexyl-3-[1-[[1-(cyclohexylcarbamoylamino)cyclohexyl]diazenyl]cyclohexyl]urea Chemical compound C1CCCCC1(N=NC1(CCCCC1)NC(=O)NC1CCCCC1)NC(=O)NC1CCCCC1 CDDDRVNOHLVEED-UHFFFAOYSA-N 0.000 description 10
- 238000002844 melting Methods 0.000 description 10
- 230000008018 melting Effects 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- POSRBSJJCMKQNU-UHFFFAOYSA-N 1-methyl-2-phenylbenzimidazole Chemical compound N=1C2=CC=CC=C2N(C)C=1C1=CC=CC=C1 POSRBSJJCMKQNU-UHFFFAOYSA-N 0.000 description 9
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 8
- 239000000047 product Substances 0.000 description 7
- 238000010992 reflux Methods 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 230000000903 blocking effect Effects 0.000 description 6
- 230000002232 neuromuscular Effects 0.000 description 6
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 5
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 5
- 229910052794 bromium Inorganic materials 0.000 description 5
- 229910052739 hydrogen Inorganic materials 0.000 description 5
- 239000001257 hydrogen Substances 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 239000003456 ion exchange resin Substances 0.000 description 4
- 229920003303 ion-exchange polymer Polymers 0.000 description 4
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 4
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 4
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 150000001649 bromium compounds Chemical group 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 229920001429 chelating resin Polymers 0.000 description 3
- 239000000460 chlorine Substances 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- FRBUNLLUASHNDJ-UHFFFAOYSA-N (2-nitrophenyl)hydrazine Chemical compound NNC1=CC=CC=C1[N+]([O-])=O FRBUNLLUASHNDJ-UHFFFAOYSA-N 0.000 description 2
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- 241000282693 Cercopithecidae Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- 229910002651 NO3 Inorganic materials 0.000 description 2
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 229940077388 benzenesulfonate Drugs 0.000 description 2
- SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 description 2
- 150000001805 chlorine compounds Chemical class 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- 150000002431 hydrogen Chemical class 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- LYGJENNIWJXYER-UHFFFAOYSA-N nitromethane Chemical compound C[N+]([O-])=O LYGJENNIWJXYER-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 2
- 229910001961 silver nitrate Inorganic materials 0.000 description 2
- ZFCDJOVFDDEYKY-UHFFFAOYSA-M silver;benzenesulfonate Chemical compound [Ag+].[O-]S(=O)(=O)C1=CC=CC=C1 ZFCDJOVFDDEYKY-UHFFFAOYSA-M 0.000 description 2
- LJRGBERXYNQPJI-UHFFFAOYSA-M sodium;3-nitrobenzenesulfonate Chemical compound [Na+].[O-][N+](=O)C1=CC=CC(S([O-])(=O)=O)=C1 LJRGBERXYNQPJI-UHFFFAOYSA-M 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- 150000004684 trihydrates Chemical class 0.000 description 2
- ZEWPNVQVWXVASF-UHFFFAOYSA-N 1-(4-methylphenyl)-2-(2-nitrophenyl)hydrazine Chemical compound [N+](=O)([O-])C1=C(C=CC=C1)NNC1=CC=C(C=C1)C ZEWPNVQVWXVASF-UHFFFAOYSA-N 0.000 description 1
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical class C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 1
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 1
- QIGCMDAAHIKAJV-UHFFFAOYSA-N 2-(4-methoxyphenyl)benzimidazol-1-amine Chemical compound NN1C(=NC2=C1C=CC=C2)C2=CC=C(C=C2)OC QIGCMDAAHIKAJV-UHFFFAOYSA-N 0.000 description 1
- OBODATJIKBKKPS-UHFFFAOYSA-N 2-(4-methylphenyl)benzimidazol-1-amine Chemical compound NN1C(=NC2=C1C=CC=C2)C1=CC=C(C=C1)C OBODATJIKBKKPS-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- KWKZYTUCBRUOFU-UHFFFAOYSA-N 2-[2-(4-methylphenyl)hydrazinyl]aniline Chemical compound NC1=C(C=CC=C1)NNC1=CC=C(C=C1)C KWKZYTUCBRUOFU-UHFFFAOYSA-N 0.000 description 1
- JWYUFVNJZUSCSM-UHFFFAOYSA-N 2-aminobenzimidazole Chemical class C1=CC=C2NC(N)=NC2=C1 JWYUFVNJZUSCSM-UHFFFAOYSA-N 0.000 description 1
- VSWICNJIUPRZIK-UHFFFAOYSA-N 2-piperideine Chemical group C1CNC=CC1 VSWICNJIUPRZIK-UHFFFAOYSA-N 0.000 description 1
- RYKLZUPYJFFNRR-UHFFFAOYSA-N 3-hydroxypiperidin-2-one Chemical compound OC1CCCNC1=O RYKLZUPYJFFNRR-UHFFFAOYSA-N 0.000 description 1
- HWBHENRINYDZRR-UHFFFAOYSA-M 3-methyl-2-(4-methylphenyl)benzimidazol-3-ium-1-amine bromide trihydrate Chemical compound [Br-].N[N+]1=C(N(C2=C1C=CC=C2)C)C2=CC=C(C=C2)C.O.O.O HWBHENRINYDZRR-UHFFFAOYSA-M 0.000 description 1
- TVTNKDHRWCTCLA-UHFFFAOYSA-M 3-methyl-2-phenylbenzimidazol-3-ium-1-amine bromide Chemical compound [Br-].N[N+]1=C(N(C2=C1C=CC=C2)C)C1=CC=CC=C1 TVTNKDHRWCTCLA-UHFFFAOYSA-M 0.000 description 1
- HXYXDTAROKJMBO-UHFFFAOYSA-O 3h-benzimidazol-1-ium-1-amine Chemical class C1=CC=C2N(N)C=[NH+]C2=C1 HXYXDTAROKJMBO-UHFFFAOYSA-O 0.000 description 1
- BNNMDMGPZUOOOE-UHFFFAOYSA-N 4-methylbenzenesulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1.CC1=CC=C(S(O)(=O)=O)C=C1 BNNMDMGPZUOOOE-UHFFFAOYSA-N 0.000 description 1
- NQUVCRCCRXRJCK-UHFFFAOYSA-N 4-methylbenzoyl chloride Chemical compound CC1=CC=C(C(Cl)=O)C=C1 NQUVCRCCRXRJCK-UHFFFAOYSA-N 0.000 description 1
- ONMOULMPIIOVTQ-UHFFFAOYSA-N 98-47-5 Chemical compound OS(=O)(=O)C1=CC=CC([N+]([O-])=O)=C1 ONMOULMPIIOVTQ-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- 206010049816 Muscle tightness Diseases 0.000 description 1
- KIWSITAZQJEXBP-UHFFFAOYSA-N N'-(2-aminophenyl)-4-methoxybenzohydrazide Chemical compound NC1=C(C=CC=C1)NNC(C1=CC=C(C=C1)OC)=O KIWSITAZQJEXBP-UHFFFAOYSA-N 0.000 description 1
- 206010029315 Neuromuscular blockade Diseases 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- HCPMLGVVDIIOPB-UHFFFAOYSA-M [Br-].N[N+]1=C(N(C2=C1C=CC=C2)C)C1=CC=C(C=C1)OC Chemical compound [Br-].N[N+]1=C(N(C2=C1C=CC=C2)C)C1=CC=C(C=C1)OC HCPMLGVVDIIOPB-UHFFFAOYSA-M 0.000 description 1
- SEGJTMVNVQLTPN-UHFFFAOYSA-L [I-].N[N+]1=C(N(C2=C1C=CC=C2)C)C2=CC=C(C=C2)C.[Br-].N[N+]2=C(N(C1=C2C=CC=C1)C)C1=CC=C(C=C1)C Chemical compound [I-].N[N+]1=C(N(C2=C1C=CC=C2)C)C2=CC=C(C=C2)C.[Br-].N[N+]2=C(N(C1=C2C=CC=C1)C)C1=CC=C(C=C1)C SEGJTMVNVQLTPN-UHFFFAOYSA-L 0.000 description 1
- 150000001266 acyl halides Chemical class 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- 150000008052 alkyl sulfonates Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- MXMOTZIXVICDSD-UHFFFAOYSA-N anisoyl chloride Chemical compound COC1=CC=C(C(Cl)=O)C=C1 MXMOTZIXVICDSD-UHFFFAOYSA-N 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- HXYXDTAROKJMBO-UHFFFAOYSA-N benzimidazol-1-amine Chemical class C1=CC=C2N(N)C=NC2=C1 HXYXDTAROKJMBO-UHFFFAOYSA-N 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229940006460 bromide ion Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- IQFVPQOLBLOTPF-HKXUKFGYSA-L congo red Chemical compound [Na+].[Na+].C1=CC=CC2=C(N)C(/N=N/C3=CC=C(C=C3)C3=CC=C(C=C3)/N=N/C3=C(C4=CC=CC=C4C(=C3)S([O-])(=O)=O)N)=CC(S([O-])(=O)=O)=C21 IQFVPQOLBLOTPF-HKXUKFGYSA-L 0.000 description 1
- HPXRVTGHNJAIIH-UHFFFAOYSA-N cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 description 1
- 230000002999 depolarising effect Effects 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 150000004678 hydrides Chemical class 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 150000004693 imidazolium salts Chemical class 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 150000004694 iodide salts Chemical group 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 230000028161 membrane depolarization Effects 0.000 description 1
- DBYWIUFNYFZUHJ-UHFFFAOYSA-N methane;silver Chemical compound C.[Ag] DBYWIUFNYFZUHJ-UHFFFAOYSA-N 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000003158 myorelaxant agent Substances 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- VLTRZXGMWDSKGL-UHFFFAOYSA-M perchlorate Inorganic materials [O-]Cl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-M 0.000 description 1
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940075930 picrate Drugs 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-M picrate anion Chemical compound [O-]C1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-M 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-O pyridinium Chemical compound C1=CC=[NH+]C=C1 JUJWROOIHBZHMG-UHFFFAOYSA-O 0.000 description 1
- 238000005956 quaternization reaction Methods 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- ADZWSOLPGZMUMY-UHFFFAOYSA-M silver bromide Chemical compound [Ag]Br ADZWSOLPGZMUMY-UHFFFAOYSA-M 0.000 description 1
- JUDUFOKGIZUSFP-UHFFFAOYSA-M silver;4-methylbenzenesulfonate Chemical compound [Ag+].CC1=CC=C(S([O-])(=O)=O)C=C1 JUDUFOKGIZUSFP-UHFFFAOYSA-M 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- GGCZERPQGJTIQP-UHFFFAOYSA-N sodium;9,10-dioxoanthracene-2-sulfonic acid Chemical compound [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-N 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 239000012258 stirred mixture Substances 0.000 description 1
- 125000002730 succinyl group Chemical group C(CCC(=O)*)(=O)* 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 210000002303 tibia Anatomy 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
- C07C243/24—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids
- C07C243/38—Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/18—Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB5221072A GB1400789A (en) | 1972-11-13 | 1972-11-13 | 1,1-azobis-benzimidazolium salts |
| GB5221072 | 1972-11-13 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI58121B FI58121B (fi) | 1980-08-29 |
| FI58121C true FI58121C (fi) | 1980-12-10 |
Family
ID=10463047
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI3404/73A FI58121C (fi) | 1972-11-13 | 1973-11-02 | Foerfarande foer framstaellning av farmakologiskt aktiva foereningar |
Country Status (12)
| Country | Link |
|---|---|
| AT (1) | AT330765B (de) |
| BE (1) | BE807010R (de) |
| CA (1) | CA987667A (de) |
| CH (1) | CH580598A5 (de) |
| ES (1) | ES420518A2 (de) |
| FI (1) | FI58121C (de) |
| FR (1) | FR2250528B2 (de) |
| GB (1) | GB1400789A (de) |
| IE (1) | IE38405B1 (de) |
| NL (1) | NL7315515A (de) |
| NO (1) | NO139561C (de) |
| ZA (1) | ZA738280B (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4083843A (en) * | 1976-06-18 | 1978-04-11 | E. I. Du Pont De Nemours And Company | 2,2'-Azobis(4,5-imidazoledicarbonitrile) and derivatives |
-
1972
- 1972-11-13 GB GB5221072A patent/GB1400789A/en not_active Expired
-
1973
- 1973-10-23 IE IE1899/73A patent/IE38405B1/xx unknown
- 1973-10-25 ZA ZA738280A patent/ZA738280B/xx unknown
- 1973-11-02 FI FI3404/73A patent/FI58121C/fi active
- 1973-11-07 BE BE137486A patent/BE807010R/xx active
- 1973-11-07 CA CA185,273A patent/CA987667A/en not_active Expired
- 1973-11-09 AT AT945373A patent/AT330765B/de not_active IP Right Cessation
- 1973-11-09 FR FR7339874A patent/FR2250528B2/fr not_active Expired
- 1973-11-12 NO NO4338/73A patent/NO139561C/no unknown
- 1973-11-13 ES ES420518A patent/ES420518A2/es not_active Expired
- 1973-11-13 NL NL7315515A patent/NL7315515A/xx not_active Application Discontinuation
- 1973-11-13 CH CH1593373A patent/CH580598A5/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ZA738280B (en) | 1974-09-25 |
| ATA945373A (de) | 1975-10-15 |
| IE38405L (en) | 1974-05-13 |
| FI58121B (fi) | 1980-08-29 |
| CA987667A (en) | 1976-04-20 |
| IE38405B1 (en) | 1978-03-01 |
| FR2250528A2 (de) | 1975-06-06 |
| NO139561B (no) | 1978-12-27 |
| CH580598A5 (de) | 1976-10-15 |
| NL7315515A (de) | 1974-05-15 |
| GB1400789A (en) | 1975-07-23 |
| AT330765B (de) | 1976-07-26 |
| FR2250528B2 (de) | 1977-10-28 |
| NO139561C (no) | 1979-04-04 |
| BE807010R (fr) | 1974-05-07 |
| ES420518A2 (es) | 1976-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3780263T2 (de) | Imidazopyridinverbindungen und verfahren zu ihrer herstellung. | |
| AU754716B2 (en) | Amide derivatives and nociceptin antagonists | |
| US5124336A (en) | Azabenzimidazole derivatives which are thromboxane receptor antagonists | |
| US5128359A (en) | Benzimidazole and azabenzimidazole derivatives which are thromboxane receptor antagonists, their methods of preparation | |
| JPS6396174A (ja) | 新規５−アルキルベンゾイミダゾール、その製法及び該化合物を含有する循環器系疾患治療剤 | |
| US4260611A (en) | Isoquinoline derivatives | |
| JPS6225670B2 (de) | ||
| Lipinski | Bioisosteric design of conformationally restricted pyridyltriazole histamine H2-receptor antagonists | |
| AU688459B2 (en) | Oxopyridinylquinoxaline derivative | |
| EP4058458A2 (de) | Neuartige funktionalisierte lactone als modulatoren des 5-hydroxytryptamin-rezeptors 7 und verfahren zu ihrer verwendung | |
| Silva et al. | Synthesis and molecular structure of new O/N/O ligands: Bis-phenol-pyridine and bis-phenol-pyrazole | |
| FI58121C (fi) | Foerfarande foer framstaellning av farmakologiskt aktiva foereningar | |
| GB1567313A (en) | 2,3-dihydro-3-hydroxy-1h-benz-(de)isoquinolin-1-one derivatives | |
| CN111116585B (zh) | 具有c-MET激酶抑制活性化合物、制备方法、组合物及用途 | |
| DE19910396C2 (de) | Anthranilsäureamide und deren Verwendung als Arzneimittel | |
| Moormann et al. | Potential antisecretory antidiarrheals. 2.. alpha. 2-Adrenergic 2-[(aryloxy) alkyl] imidazolines | |
| DE2811312A1 (de) | Neue isochinolinderivate, verfahren zu ihrer herstellung und ihre verwendung zur herstellung von arzneimitteln | |
| US4185105A (en) | 4-Phenyl-8-amino-tetrahydroisoquinolines and antidepressant use | |
| Spano et al. | 1-Adamantanecarboxylic acid amide of 4-aminoantipyrine | |
| US3849557A (en) | Pharmaceutical compositions containing 1,1-azo bis-(1h-imidazo(1,2-a)pyridinium)dibromide compounds and the use thereof | |
| US3773746A (en) | 1,1'-azo bis(1h-imidazo(1,2-a)pyridinium dibromide compounds | |
| Kohl et al. | Synthesis and central nervous system depressant activity of some 2-aryl-6-chloro-4-phenylquinazolines | |
| US3991193A (en) | Derivatives of 4(3H)-quinazolone, pharmaceutical compositions thereof and methods of use | |
| US4216229A (en) | Method for treating gastrointestinal hyperacidity or ulceration with amidinoureas | |
| JP2889150B2 (ja) | オキソピリジニルキノキサリン誘導体 |